Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight loss drugs.
Newsable Asianet News on MSN16m
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
Over one in 20 men and one in 33 women have tried the fad diet according to new data from Asda Online Doctor 😟 ...
Stock investors may look back at 2025 as the year of the takeover - one that delivered sizeable gains. "It's going to be a big year," Calamos Investments senior portfolio manager Brandon Nelson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback